Skip to content
healthcare.dev

Bumetanide

NDC 69238-1491, Bumetanide, tablet, from Amneal Pharmaceuticals NY LLC.

Product NDC
69238-1491
Status
Listed
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209724
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1491 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUMETANIDE2 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
69238-1491-169238149101100 TABLET in 1 BOTTLE (69238-1491-1)
69238-1491-569238149105500 TABLET in 1 BOTTLE (69238-1491-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9188ab17-8539-48a5-905f-ad35ab5a0b93
  • NADAC price for package 69238149101

    GET /v1/drugs/nadac/69238149101
  • NADAC price for package 69238149105

    GET /v1/drugs/nadac/69238149105

Use it

Look up 69238-1491 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1491 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69238-1491. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.